Janssen-cilag Ltd.
Clinical trials sponsored by Janssen-cilag Ltd., explained in plain language.
-
Real-World check: can a new drug tame Crohn's and colitis?
Disease control Recruiting nowThis study tracks 220 adults with moderate-to-severe ulcerative colitis or Crohn's disease who are starting guselkumab, a biologic drug. Researchers will measure how many patients achieve remission (symptom control) and whether they can stop using steroids. The goal is to see how…
Sponsor: Janssen-Cilag Ltd. • Aim: Disease control
Last updated May 13, 2026 16:04 UTC
-
New study tracks how well myeloma drugs work in everyday practice
Knowledge-focused Recruiting nowThis study observes 900 patients with relapsed/refractory multiple myeloma who received teclistamab or talquetamab outside of clinical trials. Researchers will analyze how well these treatments work, how long benefits last, and what side effects occur. The goal is to understand r…
Sponsor: Janssen-Cilag Ltd. • Aim: Knowledge-focused
Last updated May 12, 2026 13:43 UTC